Northwest Biotherapeutics NWBO

OTC: NWBO | ISIN: US66737P6007 5/06/2026

0,204 USD (-0,73%)

(-0,73%) 5/06/2026

Grafiek Northwest Biotherapeutics

Grafiek Northwest Biotherapeutics

1 dag1d -0,73%
1 week1w -7,75%
1 maand1m -4,68%
3 maanden3m -9,76%
6 maanden6m -11,52%
1 jaar1j -24,63%
5 jaar5j -87,81%

Northwest Biotherapeutics in het nieuws

Toon enkel gratis nieuws

30 april 2026 · Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform · Persbericht

21 april 2026 · Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic · Persbericht

20 november 2025 · Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility · Persbericht

24 oktober 2025 · Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed · Persbericht

27 augustus 2025 · Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. · Persbericht

18 augustus 2025 · Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman · Persbericht

11 juni 2025 · Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe